Dacomitinib: prices and alternatives
Indicated as first-line treatment for adult patients with metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 19 deletion or exon 21 L858R substitution mutations as confirmed by an approved diagnostic test.
3 products with this active ingredient from 1 manufacturer. Official prices from 14314 to 30750 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.


